CEMIPLIMAB
cemiplimab 350 mg/7 mL injection, 7 mL vial
CEMIPLIMAB (13162R)
13162R
Manner of administration:Injection
Restriction (Streamlined authority code: 15063)
Indication: Stage IV (metastatic) non-small cell lung cancer (NSCLC)
Treatment phase: Continuing treatment - 3 weekly treatment regimen
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 350 mg | # of repeats: 6 | DPMA: $7,528.96 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Libtayo
(cemiplimab 350 mg/7 mL injection, 7 mL vial)
|
||||